Association between Carotid Wall Shear Rate and Arterial Stiffness in Patients with Hypertension and Atherosclerosis of Peripheral Arteries

Table 1

Clinical and laboratory characteristics of patients.

Characteristics	Patients (n=113)
Age (years, M±SD)	57.9±10.8
Smoking (n, %)	37 (33.7%)
BMI (kg/m^2, Me (LQ; UQ))	26.0 (29.0; 31.0)
Coronary artery disease (n, %)	75 (66.4%)
Myocardial infarction (n, %)	37 (33.7%)
Coronary artery revascularization (n, %)	41 (36.3%)
Stroke (n, %)	6 (5.31%)
Intermittent claudication, (n, %)	17 (15.0%)
Type 2 diabetes mellitus (n, %)	41 (36.3%)
Laboratory findings
TC (mmol/l, M±SD)	4.83±1.15
LDL-C (mmol/l, M±SD)	2.80±1.09
HDL-C (mmol/l π, Me [LQ; UQ])	1.20 [1.04; 1.57]
Triglycerides (mmol/l, Me [LQ; UQ])	1.55 [1.07; 2.01]
eGFR (ml/min/1.73 m^2, Me [LQ; UQ])	60.0 [53.5; 70.2]
hsCRP (mg/l, Me [LQ; UQ])	1.71 [0.84; 4.37]
HbA1c (%, Me [LQ; UQ])	5.18 [4.50; 5.70]
Medication
Antiplatelets (n, %)	91 (80.5%)
Statins (n, %)	70 (61.9%)
ACE inhibitors (n, %)	80 (70.8%)
Beta-blockers (n, %)	65 (57.5%)
Diuretics (n, %)	18 (15.9%)
Calcium channel blockers (n, %)	9 (7.96%)
Oral antidiabetic medications (n, %)	25 (22.1%)

BMI: body mass index; TC: total cholesterol; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; eGFR: estimated glomerular filtration rate; hsCRP: high-sensitivity C-reactive protein; ACE: angiotensin-converting-enzyme.